| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Kayyem Jon Faiz is a Director at Inhibrx Biosciences, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 12 buys and 0 sells.
Estimated insider holdings value: $59.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2024 | INBX Inhibrx Biosciences, Inc. | Director | Buy | 107,186 | $14.21 | $1,523,619.50 | +79.6% | -6.9% | +468.7% | |
| Jun 5, 2024 | INBX Inhibrx Biosciences, Inc. | Director | Buy | 57,549 | $17.32 | $997,024.17 | +2.6% | -5.6% | -23.7% | |
| Jun 4, 2024 | INBX Inhibrx Biosciences, Inc. | Director | Buy | 286,786 | $17.18 | $4,927,579.86 | +6.1% | -7.3% | -24.5% | |
| Nov 21, 2022 | BDSX Biodesix Inc | Director | Buy | 173,913 | $1.15 | $199,999.95 | New | +76.9% | +1.5% |